| Literature DB >> 35521558 |
Qi Yang1,2, Nian Jiang1,2, Han Zou1,2, Xuning Fan3, Tao Liu3, Xi Huang4,5,6, Siyi Wanggou1,2, Xuejun Li1,2.
Abstract
Background: EGFR amplification and/or mutation are found in more than half of the cases with glioblastoma. Yet, the role of chromatin interactions and its regulation of gene expression in EGFR-amplified glioblastoma remains unclear.Entities:
Keywords: 3D genomic; Astrocytes; DE, Differentially expressed; FDR, False discovery rate; GBM, Glioblastoma multiform; Glioblastoma; Hi-C; ICE, Iterative correction and eigenvector decomposition; IDE, Distance decay exponent; PCC, Pearson’s correlation coefficient; SV, Structure variation; Structure Variation; TAD, Topological associating domain; Tumorigenesis; WGS, Whole-genome sequencing
Year: 2022 PMID: 35521558 PMCID: PMC9062087 DOI: 10.1016/j.csbj.2022.04.007
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 6.155
Fig. 1(A) ICE normalized contact maps at 500-kb resolution of HA1800 (top), A172 (middle) and A172 minus HA1800 (bottom). (B) Merged intra-chromosome IDE curve of A172 and HA1800 on all chromosomes. (C) Cumulative intra-chromosome interactions by genomic distance of A172 and HA1800 (left). Cumulative percentage of intra-chromosome interaction by genomic distance of A172 and HA1800 (right). (D) Pearson correlation coefficient matrix of collapsed inter-chromosome contact map from HA1800 and A172. Chromosomes are grouped by unsupervised hierarchical clustering. (E) 3D reconstruction of relative spatial distribution of chromatin based on Hi-C data. Chromatin relaxation of chromosome 6 and chromosome 8 in A172 (arrows). Asterisk shows chromosome territories entanglement of chromosome 6 and chromosome 8. (F) 3D reconstruction of relative spatial distribution of chromatin based on Hi-C data. Chromosome territories entanglement of chromosome 9 and chromosome 13 in A172. (G) Comparison of Euclidean distance to nuclear center between small and large chromosome clusters in HA1800 (left) and A172 (right). Dots represent individual TADs. Dotted lines represent mean value of each group. Non-parametric Wilcoxon test was used for statistics.
Fig. 2(A) Genome-wide landscape of switched compartments and differentially expressed genes from HA1800 to A172. (B) Proportion of compartments and compartment switch patterns from HA1800 to A172. (C) Ratio between activated domains (B to A switch) and deactivated domains (A to B switch) in each chromosome. (D) Differentially expressed genes in activated (B to A switch), deactivated (A to B switch) and stable domains (A to A or B to B) between HA1800 and A172. (E) Contingency tables for compartment switch and differential gene expression between the two cell lines. A2B, A-to-B compartment switch: A in HA1800 switched to B in A172. B2A, B-to-A compartment switch: B in HA1800 switched to A in A172. Up-regulation means the gene has significantly higher expression in A172, and vice versa. (F) Enriched GO pathways of upregulated genes at B-to-A switched domains. (G) Differentially expressed HOX gene family at B-to-A switched domains. (H) Contact map and compartment comparison on chromosome 12 between HA1800 and A172. Arrow shows B-to-A compartment switch spanning HOTAIR domain. Magnified RNA-seq shows gene expression in this domain.
Fig. 3(A) Genome-wide landscape of insulation score, TAD boundaries and differentially expressed genes in HA1800 and A172. Insulation score and TAD boundaries were inferred with contact map at 50 kb. (B) Proportion of stable and altered TADs between HA1800 and A172 in each chromosome. (C) Boxplots for TAD size in A172, HA1800 and altered TADs between them. Wilcoxon test was used for statistics. **** refer to p value < 0.0001. (D) Volcano plot of Differentially expressed genes between HA1800 and A172 in altered TADs. (E) Differentially expressed oncogenes in altered TADs between HA1800 and A172 in altered TADs. (F) Contact map, TAD boundaries and RNA-seq in altered TAD domain spanning TRPM2.
Fig. 4(A) Length comparison of all the loops in HA1800 and A172. Ridge plots show loop length distribution. Bar plots show statistics. Solid lines show median length. Dotted lines show average length. Wilcoxon test was used for statistics. **** refer to a p value < 0.0001. *** refer to a p value < 0.001. (B) Differentially expressed genes located at anchors of altered loops. (C) Enriched pathways of genes at anchors of altered loops (Upper). Enriched pathways of differentially expressed genes at anchors of altered loops (Lower). (D) Differentially expressed oncogenes (in the red rectangle) and tumor repressors (in the blue rectangle) at anchors of altered loops. (E) Transcriptome profiles of differentially expressed genes located at anchors of specific loops enriched in KEGG-CANCER-pathway. (F) Specific loops on chromosome 16 of A172 and HA1800, contact map of the region from 18 Mb to 27 Mb and the region from 51 Mb to 74 Mb.
Fig. 5(A) Genomic landscape of chromosomes in A172 cell line. Compartment associated PC1 eigenvalue, log2 fold change of differentially expressed genes, loci of SNPs, DNA domains of copy number variations (CNVs) and structure variations (SVs), and DNA translocation events are integrated. (B) The proportion of TAD boundaries affected by structure variations between all boundaries and altered boundaries. The Chi-square test was used for statistics. *** represents a p-value < 0.001, * represents a p-value < 0.05, ns represents a p-value > 0.05. (C) The proportion of loop anchors affected by structure variations between all anchors and altered anchors. The Chi-square test was used for statistics. *** represents a p-value < 0.001, * represents a p-value < 0.05, ns represents a p-value > 0.05. (D) Hi-C contact map of chromosome 7 in HA1800 (left) and A172 (right). DNA domains from 45.0 Mb to 64.3 Mb are magnified. Contact maps show obvious neo-TAD boundary and emerged interactions spanning chromosome 7p11.2. TAD in HA1800 is framed by green, and neo-TADs in A172 are labeled by fuchsia. The resolution of the contact map is 50 kb. (E) Magnified contact map and loop comparison between A172 and HA1800, centering EGFR from chr7 48.0 Mb to 58.0 Mb. The arrow shows A172 specific interaction connecting LINC01446 and EGFR. A Tandem duplication breakpoint is identified by whole-genome sequencing (WGS). (F) DNase signal, H3K27ac signal, H3K4me3 signal of K562, H1, and IMR90 cell lines help to identify enhancer of LINC01446. RNA-seq of HA1800 and A172 reveals altered expression of LINC01446 and EGFR. (G) Schematic of the locus in HA1800 and A172 (top and middle). LINC01446 enhancer is labeled in green; the Tandem duplication domain is labeled in the red frame. Linear DNA schematic (bottom) shows neo-TAD in A172. TSS, transcription start site. (H) Working model of 7p11.2 duplication activates EGFR expression in EGFR amplified glioblastoma by novel enhancer-promoter interaction connecting LINC01446 and EGFR via neo-TAD.
Fig. 6(A) The proportion of differentially expressed genes among all mapped genes in RNA-seq. (B) The proportion of genes at activated, deactivated and stable compartment domains (left). The proportion of differentially expressed genes at different compartment domains (right). A2B, compartment A-to-B switch from HA1800 to A172. B2A, compartment B-to-A switch from HA1800 to A172. (C) Contingency tables for compartment switch and differential gene expression between the two cell lines. DEG, differentially expressed gene. NDEG, non-differentially expressed gene. (D) Schematic of compartment activation in glioblastoma. (E) Gene distribution in stable and altered TADs (left). The proportion of differentially expressed genes in stable and altered TADs (right). (F) Contingency tables for TAD alteration and differential gene expression between the two cell lines. DEG, differentially expressed gene. NDEG, non-differentially expressed gene. (G) Neo-TADs, oncogene activation and tumor repressor deactivation in glioblastoma. Alteration of TAD boundaries (disappearing, emerging or shifting) emerges neo-TADs in glioblastoma, contributing to oncogene activation and tumor repressor deactivation. (H) The proportion of genes located at anchors of altered loops in whole-genome (left). The proportion of differentially expressed genes in genes at anchors of altered loops (right). (I) Contingency tables for loop alteration and differential gene expression between the two cell lines. DEG, differentially expressed gene. NDEG, non-differentially expressed gene. (J) Loop alteration, oncogene activation, and tumor repressor deactivation in glioblastoma. Neo-loop emerging activates oncogene expression (left), and the disappeared loop deactivates tumor repressor (right). (K) Schematic of major findings in this study. Compared with chromatin conformation of astrocytes, glioblastoma shows alterations at various levels.